CLINICAL_TRIALS
trial_result
· 2025-08-27
Clinical Trial Update: Mepolizumab for the Treatment of Chronic Spontaneous Urticaria [EARLY_Phase 1]
Summary
An early Phase 1 trial evaluating mepolizumab for chronic spontaneous urticaria has completed enrollment and posted results in 2025.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Chronic Spontaneous Urticaria | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2025-08-27